- Home
- GNLN vs BFRI Comparison
GNLN vs BFRI Comparison
Compare GNLN & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- BFRI
- Stock Information
- Founded
- GNLN 2005
- BFRI 1997
- Country
- GNLN United States
- BFRI United States
- Employees
- GNLN N/A
- BFRI N/A
- Industry
- GNLN Durable Goods
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- BFRI Health Care
- Exchange
- GNLN Nasdaq
- BFRI Nasdaq
- Market Cap
- GNLN 12.9M
- BFRI 11.1M
- IPO Year
- GNLN 2019
- BFRI 2021
- Fundamental
- Price
- GNLN $3.26
- BFRI $0.79
- Analyst Decision
- GNLN
- BFRI Strong Buy
- Analyst Count
- GNLN 0
- BFRI 1
- Target Price
- GNLN N/A
- BFRI $2.75
- AVG Volume (30 Days)
- GNLN 39.6K
- BFRI 193.0K
- Earning Date
- GNLN 11-14-2025
- BFRI 11-12-2025
- Dividend Yield
- GNLN N/A
- BFRI N/A
- EPS Growth
- GNLN N/A
- BFRI N/A
- EPS
- GNLN N/A
- BFRI N/A
- Revenue
- GNLN $4,653,000.00
- BFRI $37,164,000.00
- Revenue This Year
- GNLN $1,541.21
- BFRI $9.70
- Revenue Next Year
- GNLN N/A
- BFRI $12.58
- P/E Ratio
- GNLN N/A
- BFRI N/A
- Revenue Growth
- GNLN N/A
- BFRI 5.11
- 52 Week Low
- GNLN $2.68
- BFRI $0.54
- 52 Week High
- GNLN $1,537.54
- BFRI $1.87
- Technical
- Relative Strength Index (RSI)
- GNLN 52.51
- BFRI 37.90
- Support Level
- GNLN $2.79
- BFRI $0.71
- Resistance Level
- GNLN $3.48
- BFRI $0.83
- Average True Range (ATR)
- GNLN 0.24
- BFRI 0.10
- MACD
- GNLN 0.07
- BFRI -0.02
- Stochastic Oscillator
- GNLN 78.75
- BFRI 20.73
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.